
Throughout February, March And April, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To Floating Doctors
November 7, 2024
Symptoms Six Weeks After COVID-19 are Reduced Among US Health Care Personnel Receiving Additional Vaccine Doses During the Omicron Period, December 2021–April 2022 |
Microbial Dynamics and Pulmonary Immune Responses in COVID-19 Secondary Bacterial Pneumonia |
Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19
October 31, 2024
Repeated COVID-19 mRNA-based Vaccination Contributes to SARS-CoV-2 Neutralizing Antibody Responses in the Mucosa |
SARS-CoV-2 XBB.1.5 mRNA Booster Vaccination Elicits Limited Mucosal Immunity | Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022 | Nirmatrelvir Plus Ritonavir Reduces COVID-19 Hospitalization and Prevents Long COVID in Adult Outpatients |
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo - The ACTIV-6 Randomized Clinical Trial | Clinical and Functional Assessment of SARS-CoV-2 Sequelae among Young Marines – A Panel Study
October 24, 2024
The Risk of SARS-CoV-2 Transmission in Community Indoor Settings |
Relative Effectiveness of the NVX-CoV2373 Vaccine Compared With the BNT162b2 Vaccine in Adolescents |
Viral and Symptom Rebound Following Anti-SARS-CoV-2 Monoclonal Antibody Therapy in a Randomized Placebo-controlled Trial |
The Importance of Including Long COVID Outcomes When Developing Novel Treatments for Acute COVID-19 | The Persistence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) after SARS-CoV-2 Infection
October 17, 2024
Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in Medicare Beneficiaries |
Remdesivir-associated Survival Outcomes among Immunocompromised Patients Hospitalized for COVID-19 |
Remdesivir Effectiveness in Reducing the Risk of 30-day Readmission in Vulnerable Patients |
Measurement of Circulating Viral Antigens Post-SARS-CoV-2 Infection in a Multicohort Study | Driving Under the Cognitive Influence of COVID-19 | Long COVID Facts and Findings
October 10, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO) |
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type | Quantitative Susceptibility Mapping at 7 T in COVID-19: Brainstem Effects and Outcome Associations
October 3, 2024
Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection |
SARS-CoV-2-specific Plasma Cells are Not Durably Established in the Bone Marrow Long-lived Compartment after mRNA Vaccination |
Effects of Losartan on Patients Hospitalized for Acute COVID-19 |
Mechanisms of Long COVID and the Path Toward Therapeutics |
Post-hospitalization COVID-19 Cognitive Deficits
Situation Dashboards

World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)

Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU

COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources

Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.